Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Harrington

Showing results (341-350 of 368) with videos related to

Pageof 37
Sort By:
Practical Radiation Oncology|March 31, 2016
Robustness quantification methods comparison in volumetric modulated arc therapy to treat head and neck cancerWei Liu, Samir H Patel, Jiajian Jason Shen, et al.
Public Health|November 18, 2023
Lessons learnt from the COVID-19 pandemic in selected countries to inform strengthening of public health systems: a qualitative studyK Cardwell, B Clyne, N Broderick, et al.
Nanoscale|October 30, 2023
MOF-based heterogeneous catalysis in continuous flow <i>via</i> incorporation onto polymer-based spherical activated carbon supportsAnthony Griffiths, Sarah L Boyall, Pia Müller, et al.
Nanotechnology|May 11, 2012
Active glass-polymer superlattice structure for photonic integrationZhanxiang Zhao, Gin Jose, Toney T Fernandez, et al.
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2019
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian CancerMatthew Schwede, Levi Waldron, Samuel C Mok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
Cancer Cell|March 15, 2011
The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant gliomaShwetal Mehta, Emmanuelle Huillard, Santosh Kesari, et al.
Plos Genetics|June 1, 2011
COL4A1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and Walker-Warburg syndrome in humansCassandre Labelle-Dumais, David J Dilworth, Emily P Harrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancerElizabeth A Chrischilles, Jane F Pendergast, Katherine L Kahn, et al.
Pageof 37

Showing results (341-350 of 368) with videos related to

Sort By:
Pageof 37
Practical Radiation Oncology|March 31, 2016
Robustness quantification methods comparison in volumetric modulated arc therapy to treat head and neck cancerWei Liu, Samir H Patel, Jiajian Jason Shen, et al.
Public Health|November 18, 2023
Lessons learnt from the COVID-19 pandemic in selected countries to inform strengthening of public health systems: a qualitative studyK Cardwell, B Clyne, N Broderick, et al.
Nanoscale|October 30, 2023
MOF-based heterogeneous catalysis in continuous flow <i>via</i> incorporation onto polymer-based spherical activated carbon supportsAnthony Griffiths, Sarah L Boyall, Pia Müller, et al.
Nanotechnology|May 11, 2012
Active glass-polymer superlattice structure for photonic integrationZhanxiang Zhao, Gin Jose, Toney T Fernandez, et al.
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2019
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian CancerMatthew Schwede, Levi Waldron, Samuel C Mok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
Cancer Cell|March 15, 2011
The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant gliomaShwetal Mehta, Emmanuelle Huillard, Santosh Kesari, et al.
Plos Genetics|June 1, 2011
COL4A1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and Walker-Warburg syndrome in humansCassandre Labelle-Dumais, David J Dilworth, Emily P Harrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancerElizabeth A Chrischilles, Jane F Pendergast, Katherine L Kahn, et al.
Pageof 37